Table 2 Distribution of HPV types in ICC specimens from Italy
HPV type-specific positive cases (n) | HPV prevalence (95% CI) (*) | Relative HPV type contribution (95% CI) (**) | |
|---|---|---|---|
Single types | 111 | 82.2 (75.4-88.8) | 91.7 (85.3-96.0) |
HPV16 | 71 | 53.0 (44.2-61.7) | 58.7 (49.4-67.5) |
HPV18 | 12 | 9.0 (4.7-15.1) | 9.9 (5.2-16.7) |
HPV31 | 5 | 3.7 (1.2-8.5) | 4.1 (1.4-9.4) |
HPV45 | 5 | 3.7 (1.2-8.5) | 4.1 (1.4-9.4) |
HPV58 | 5 | 3.7 (1.2-8.5) | 4.1 (1.4-9.4) |
HPV33 | 4 | 3.0 (0.8-7.5) | 3.3 (0.9-8.2) |
HPV35 | 2 | 1.5 (0.2-5.3) | 1.7 (0.2-5.8) |
HPV51 | 2 | 1.5 (0.2-5.3) | 1.7 (0.2-5.8) |
HPV52 | 2 | 1.5 (0.2-5.3) | 1.7 (0.2-5.8) |
HPV42 | 1 | 0.7 (0.0-4.1) | 0.8 (0.0-4.5) |
HPV56 | 1 | 0.7 (0.0-4.1) | 0.8 (0.0-4.5) |
HPV70 | 1 | 0.7 (0.0-4.1) | 0.8 (0.0-4.5) |
Multiple types | 6 | 4.5 (1.7-9.5) | 5.0 (1.8-10.5) |
HPV 16&18 | 1 | 0.7 (0.0-4.1) | 0.8 (0.0-4.5) |
HPV 45&51 | 1 | 0.7 (0.0-4.1) | 0.8 (0.0-4.5) |
HPV 31&42 | 1 | 0.7 (0.0-4.1) | 0.8 (0.0-4.5) |
HPV 31&52 | 1 | 0.7 (0.0-4.1) | 0.8 (0.0-4.5) |
HPV 6&53&66 | 1 | 0.7 (0.0-4.1) | 0.8 (0.0-4.5) |
HPV 53&56&58 | 1 | 0.7 (0.0-4.1) | 0.8 (0.0-4.5) |
HPVX (Unknown type) | 4 | 3.0 (0.1-5.9) | 3.3 (0.9-8.2) |
Potential vaccine impact (***) | |||
HPV16, 18, 16&18 | 84 | 62.7 (53.9-70.9) | 69.4 (60.4-77.5) |
Total HPV positive cases | 121 | 90.3 (84.0-94.7) | 100.0 |
Total HPV analyzed cases | 134 |